Data protection Impressum

Medtech

PeriVision, a Bern-based start-up, has received CE Marking for its VisionOne device, allowing it to be sold throughout Europe.

PeriVision receives CE marking for its VisionOne glaucoma diagnostics device

4 November 2024

Distalmotion has received FDA approval for its Dexter Surgical Robot, allowing it to enter the U.S. outpatient market.

Distalmotion secures FDA approval for its Dexter surgical robot

29 October 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (October 2024)

29 October 2024

ONWARD Medical has raised EUR 50 million through an upsized private placement, establishing a strategic partnership with Ottobock. The funds will drive ONWARD’s research and commercialization of spinal cord therapies, with plans for collaboration with Ottobock on future innovations.

ONWARD Medical raises EUR 50 million and welcomes a new strategic partner

28 October 2024

Certification Experts, a division of Kader Group, has opened a new office on Lausanne's Biopôle campus, reinforcing its presence in Switzerland to meet rising demand for compliance and regulatory consulting in the medical device and pharmaceutical sectors.

Certification Experts expands medtech services with new office at Biopôle

28 October 2024

machineMD has received EU-MDR Class IIa certification for its neos™ neuro-ophthalmic diagnostic device, setting a new standard for eye movement and pupil function assessment in neurology and ophthalmology.

machineMD’s neos receives EU-MDR Class IIa Certification to advance neuro-ophthalmic diagnostics

14 October 2024

PeriVision, in collaboration with Inselspital and the University of Bern, has received CHF 1.1 million to develop novel, AI-driven eye tests for retinal diseases like age-related macular degeneration and diabetic retinopathy.

PeriVision secures CHF 1.1 million grant for retinal disease research

1 October 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (September 2024)

30 September 2024

ten23 health celebrates the opening of its VIVA2® facility in Visp, increasing the region's sterile pharmaceutical production capacity and strengthening its position in the life sciences sector.

ten23 health inaugurates VIVA2 sterile production facility in Visp

24 September 2024

Novostia has raised CHF 5.6 million in a new financing round and appointed Soad El Ghazouani as CEO to accelerate the development of its TRIFLO heart valve technology.

Novostia secures CHF 5.6 million to accelerate the development of its heart valve

24 September 2024

1 2 3 4 5 6 7 8 9 … 17